baber/WOPTO huggingface dataset:
Patent AU-2017200623-A1 (AU)
Title: Positioning tool with extendable landing dogs
Inventor: BRASSEAUX JASON J
IPC: E21B43/10
Filed: 2017-01-31
Abstract: POSITIONING TOOL WITH EXTENDABLE LANDING DOGS A positioning tool (80) can include a mandrel (82) and an engagement device (86) reciprocably disposed on the mandrel (82). The engagement device (86) can include at least one engagement member (88) and at least one landing dog (90). The mandrel (82) can displace relative to the engagement device (86) in response to engagement between the engagement member (88) and at least one internal profile (120) in an outer tubular string (118), and the landing dog (90) can extend outward in response to displacement of the mandrel (82) in a selected longitudinal direction relative to the engagement device (86). A system for use in a well can include a tubular string (118) and a positioning tool (80) reciprocably disposed in the tubular string. The positioning tool (80) can include a landing dog (90) that extends outward from a retracted position to engage one or more internal profiles (120) of the tubular string (118), in response to a pattern of reciprocation of the positioning tool (80) in the tubular string. -6---1 -- 80 96 - --- -96 92 92- ---- ~ 94"'
Patent AU-2017203144-A1 (AU)
Title: Contact trigger release needle guard with elastic spring
Inventor: SHOONMAKER RYAN
IPC: A61M5/32
Filed: 2017-05-11
Abstract: CONTACT TRIGGER RELEASE NEEDLE GUARD WITH ELASTIC SPRING A needle guard (100) device mountable to a pre-filled syringe (50) in its ready-to-fill state. The device (100) includes a device shield (20) interconnected to a lock collar (10) with flexible member (30) and biased to move relative to the lock collar. The lock collar interfaces with the syringe neck to attach the device to the syringe. As the device shield moves proximally, rotation arms of the lock collar interact with angled cutouts in the device shield, causing the device shield to rotate relative to the lock collar and disengaging one or more keys on the device shield from one or more keyways in the lock collar triggering the device shield to move from a first configuration in which the device shield is retractable to expose a syringe sharp to a second configuration in which the device shield is fixedly positioned to cover the syringe sharp.
Patent AU-2017204748-A1 (AU)
Title: (--)-Huperzine A processes and related compositions and methods of treatment
Inventor: HERZON SETH
IPC: A61K31/439
Filed: 2017-07-11
Abstract: Abstract The invention provides (1) processes for making substantially-pure (-) 5 huperzine A and substantially-pure (-) huperzine A derivatives; (2) compositions useful in making substantially-pure (-) huperzine A and substantially-pure (-) huperzine A derivatives; and (3) methods of treating or preventing neurological disorders using substantially-pure (-) huperzine A and substantially-pure (-) huperzine A derivatives. '5
Patent AU-2017206443-A1 (AU)
Title: A device and method for providing a measure of a circumference of a body part
Inventor: ETTRUP JENS
IPC: A61B5/107
Filed: 2017-01-13
Abstract: The present disclosure relates in general to a device and a method for providing a measure of a circumference of a body part. More specifically, the present disclosure relates to how to provide a measure of a circumference of a body part, wherein the body part may have swelled, such that it for example can be observed whether the body part swells further or less. Most specifically, the swelled body part may be swelled due to oedema and/or lymphoedema.
Patent AU-2017211414-A1 (AU)
Title: Accepting issuer credentials at checkout
Inventor: PURVES THOMAS
IPC: G06Q20/20
Filed: 2017-01-27
Abstract: A computer-implemented method presents on a merchant checkout graphical user interface associated with a payment processor widget. The payment processor widget determines affiliations of a plurality of accounts and a plurality of issuers of a user. The payment processor widget via the merchant checkout graphical user interface defines at least one selectable graphic configured for receiving interactions of the user on the selectable graphic. In response to receiving the selection of the selectable graphic, the payment processor widget presents a field within the merchant checkout graphical user interface for receiving a credential from the user associated with an authentication widget of the particular issuer. The authentication widget communicates the credential to the particular issuer for authentication of the user. In response to receiving a successful authentication indicator from the particular issuer, the payment processor widget displays a message indicating that a transaction was approved.
Patent AU-2017235321-A1 (AU)
Title: Method and composition for treating inflammatory Bowel Disease
Inventor: RAMER MARC
IPC: A61K35/22
Filed: 2017-03-14
Abstract: Methods and compositions for treating diseased or damaged tissue, such as inflammatory Bowel Disease, e.g., Ulcerative Colitis, include tissue regeneration using stem cells or tissue grafts which stimulate stem cell migration to the damaged tissue. The tissue grafts can be extracellular matrix (ECM) material, such as tissue-specific extracellular matrix (TS-ECM). The methods can also include mucosal resection of the damaged or diseased tissue prior to placement of the graft.
Patent AU-2017238168-A1 (AU)
Title: DNA antibody constructs and method of using same
Inventor: WEINER DAVID B
IPC: C12N9/64
Filed: 2017-03-21
Abstract: Disclosed herein is a composition comprising the combination of a nucleic acid sequence encoding a desired polypeptide that elicits an immune response in a mammal and a nucleic acid sequence encoding an antibody, a fragment thereof, a variant thereof, or a combination thereof.
Patent AU-2017245831-A1 (AU)
Title: Improvements in or relating to flow balancing
Inventor: DOUGLAS ANTHONY
IPC: B01L3/00
Filed: 2017-04-04
Abstract: A device for controlling a fluid flow in an array of fluid pathways on a microfluidic chip is provided. The device comprising: two or more resistors provided upstream of the chip wherein each upstream resistor is configured to provide a resistance at an upstream end of a fluid pathway;two or more resistors provided downstream of the chip wherein each downstream resistor is configured to provide a resistance at a downstream end of a fluid pathway,wherein the values of the resistances are selected in order to control a proportion of fluid that flows through each fluid pathway.
Patent AU-2017293437-A1 (AU)
Title: Collapsible tobacco container
Inventor: VAN LANCKER PIETER
IPC: A24F23/02
Filed: 2017-06-28
Abstract: A container (100) includes a front wall (130), a back wall (140), first (120) and second opposing sidewalls, a foldable top (110), and a bottom (150). An interior for storing consumer goods is defined between the front wall, the back wall, the first and second side walls, the top and the bottom. Each side wall has three or more fold lines (122), which form two or more indents extending along the side wall from the bottom to the top. The fold lines of the first side wall are aligned with the fold lines of the second side wall. The container is expandable and collapsible such that the distance between the front wall and the back wall increases as the container is expanded and decreases as the container is collapsed. The top forms a fin (115) when the top is unfolded.
Patent AU-2017306698-A1 (AU)
Title: Blood brain barrier model and methods of making and using the same
Inventor: WICKS ROBERT T
IPC: A61K35/44
Filed: 2017-08-04
Abstract: Provided herein is an
Patent AU-2017312743-A1 (AU)
Title: Method for facilitating dispensing fuel into a vehicle
Inventor: SHAH DARSHAN
IPC: G06Q20/32
Filed: 2017-07-25
Abstract: A method for facilitating to dispense of fuel into a vehicle is provided. The method includes receiving from the vehicle, a vehicle identifier for identifying the vehicle, retrieving payment vehicle, retrieving payment details, for payment for the fuel, from a remote server based on the vehicle identifier, and authorizing dispensing the fuel into the vehicle in accordance with the payment details.
Patent AU-2017317607-A1 (AU)
Title: Cell population seeding in dermal matrices for endocrine
Inventor: GREENWOOD JOHN
IPC: A61L27/56
Filed: 2017-10-19
Abstract: A method of delivering a cell derived factors to a subject is described, which includes implanting a matrix material into an intracutaneous location in the subject that results in increased vascularisation and subsequently efficient delivery of the required cell derived factors to the subject. The implanted matrix material can be loaded in-situ or alternatively pre-loaded and inserted into the appropriate location depending on requirements.
Patent AU-2017373239-A1 (AU)
Title: Crystalline forms of a bromodomain and extraterminal protein inhibitor drug, processes for preparation thereof, and use thereof
Inventor: CHEN MINHUA
IPC: A61P9/10
Filed: 2017-12-08
Abstract: Provided are a crystal form of a bromodomain protein inhibitor 2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxyquinazolin-4(3H)-one represented by Formula I, a preparation method and a use thereof. The present invention belongs to the field of medicine. The crystal forms are crystal form CS2, crystal form CS8, crystal form CS13, crystal form CS20, crystal form CS1, crystal form CS7, crystal form CS9, crystal form CS11, and crystal form CS4, and can be used to prepare drugs for treating cardiovascular, cholesterol, or lipid-related disorders.
Patent AU-2017380092-A1 (AU)
Title: Omega-3 fatty acid composition for preventing and/or treating cachexia
Inventor: NYHEIM HILDE
IPC: A61P3/00
Filed: 2017-12-22
Abstract: The present invention relates to compositions of polyunsaturated omega-3 fatty such as of (5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenoicacid (EPA) and (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoicacid (DHA) for preventing and/or treating cachexia in a subject. Particularly, the compositions comprise a certain amount of the fatty acids as monoacylglycerides. Further, the compositions of omega-3 fatty acids preferably comprise a certain ratio of the fatty acids as mono-, di- and triacylglycerides as this enhances the digestion and uptake of the EPA and DHA fatty acids. Further, the invention relates to a method of preventing and/or treating cachexia in a subject, including administering a composition of EPA and DHA to the subject, wherein at least a part of the fatty acids are provided in monoacylglyceride form.
Patent AU-2017385015-A1 (AU)
Title: Accessing historical content items of a content management system through placeholders
Inventor: CONG SHI
IPC: G06F16/00
Filed: 2017-11-07
Abstract: The present technology provides an interface and system for generating a previous version of a directory structure that can be useful in the restoration of a directory or file. The system, methods and non-transitory computer-readable storage media include receiving a request for a previous version of a directory structure at an indicated date, querying a content management system for placeholder content items associated with the previous version of the directory structure at the indicated date, receiving the placeholder content items, and generating a read-only copy of at least a portion of the previous version of the directory structure at the indicated date based on the placeholder content items, wherein the read-only copy of the directory structure is separate from the directory structure at a current date.
Patent AU-2018200915-A1 (AU)
Title: Prevention of Adverse Effects Caused by CD3 Specific Binding Domains
Inventor: ZUGMAIER GERHARD
IPC: A61K39/395
Filed: 2018-02-07
Abstract: The present invention relates to a glucocorticoid (GC) for use in the amelioration, treatment or prophylaxis of neurological/psychiatric adverse events caused by a CD3 binding domain. Kits comprising a GC, a CD3 binding domain and instructions for use which indicate that the GC is 5 to be employed for the treatment amelioration and/or prophylaxis of neurological adverse events caused by said CD3 binding domain, are also disclosed.
Patent AU-2018204591-A1 (AU)
Title: Small molecule enhancer for dendritic cell cancer vaccines
Inventor: BACHOVCHIN WILLIAM W
IPC: C12N5/07
Filed: 2018-06-25
Abstract: Abstract Disclosed is a method of treating cancer, comprising administering to a mammal in need thereof a therapeutically effective amount of a compound that inhibits a plurality of mammalian DASH serine proteases. Also disclosed is a method of (a) increasing 5 antitumor immunity, (b) stimulating or enhancing an immune response, (c) treating a condition characterized by abnormal cell proliferation, (d) increasing cytokine and/or chemokine production, or (e) stimulating or enhancing production of T-cells, in a mammal, comprising administering to a mammal in need thereof an effective amount of a compound that inhibits a plurality of mammalian DASH serine proteases. For 10 example, the compound that inhibits a plurality of mammalian DASH serine proteases may be t-butylGly-boroPro.
Patent AU-2018219385-A1 (AU)
Title: Orthopaedic foot bed and method for producing an orthopaedic foot bed
Inventor: BÄUMER CHRISTOPH
IPC: A43B7/14
Filed: 2018-01-23
Abstract: Orthopaedic foot bed (1) for a shoe (2) with a foot support surface (3), wherein the foot support surface (3) is formed by a plane base surface (4). The foot bed (1) has a multiplicity of knobs which are distributed in a predefined manner and by which the stimulation points in the sole are stimulated in a targeted manner, as a result of which the neurological, biotensegrity and liquid-dynamic system of the human body can in turn be improved. Through the improvement thereby achieved, it is possible to address and improve certain aspects of human health, which in particular include the gait pattern and posture of the human body. Moreover, by means of the invention, the transport of the lymphatic and venous liquids ("heart of feet function" of the sole) can be excited and intensified.
Patent AU-2018224326-A1 (AU)
Title: Novel codon-optimized CFTR mRNA
Inventor: DIAS ANUSHA
IPC: C07K14/47
Filed: 2018-02-27
Abstract: The present invention provides, among other things, improved methods and pharmaceutical compositions for treating cystic fibrosis based on codon optimized mRNA encoding a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein.
Patent AU-2018241195-A1 (AU)
Title: Electric motor operated kitchen appliance
Inventor: FRIELINGHAUS ROBERT
IPC: A47J43/08
Filed: 2018-10-08
Abstract: Abstract The invention relates to an electric motor operated kitchen appliance (1) comprising a base unit (2) having an electric motor and a preparation vessel (3), which can be 5 connected to the base unit (2) and into which a rotating element (5) protrudes, which can be rotationally driven by means of the electric motor, wherein a grinding element (6), which, with a grinding area (7) of a grinding vessel (8) held on the preparation vessel (3), forms a grinder (9), can be connected to the rotating element (5). To advantageously further develop the kitchen appliance (1), it is proposed that the 10 grinding element (6) is connected to the rotating element (5) via a coupling element (10) having at least one elastic partial area. 16 28 21 1 )2 22 7]I 14 15 19 4 14
Patent AU-2018260867-A1 (AU)
Title: Adjustable sharpener
Inventor: CHALFANT LOUIS
IPC: B24D15/06
Filed: 2018-11-07
Abstract: An adjustable sharpener including a body having two sharpening slots, a first arm with a first abrasive element connected to a second arm with a second abrasive element, and a third arm with a third abrasive element connected to a fourth arm with a fourth abrasive element. The first and second abrasive elements are positioned in the first sharpening slot, and the third and fourth abrasive elements are positioned in the second sharpening slot. The adjustable sharpener also includes an adjuster connected to the body and an adjustment assembly connected to the adjuster, the first arm and the third arm. Linear movement of the adjuster causes rotational movement of the first arm and the third arm. In this regard, the adjuster allows the user to manually increase or decrease the sharpening angle between the abrasive elements in the sharpening slots. 22 26 14 28 24 12 14 28 32 68- 68
Patent AU-2018261720-A1 (AU)
Title: Compositions and methods related to xCT antibodies
Inventor: PERICLE FEDERICA
IPC: C07K16/46
Filed: 2018-04-30
Abstract: Certain embodiments are directed to therapeutic compositions having an xCT specific antibody.
Patent AU-2018287131-A1 (AU)
Title: Pesticidal mixtures comprising a pyrazole compound
Inventor: REINHARD ROBERT
IPC: A01N43/80
Filed: 2018-06-21
Abstract: Pesticidal mixtures comprising as active compounds 1) at least one pyrazole compound A of formula (I) wherein the variables are as defined in the specification, and 2) at least one further compound B selected from 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)- 4H-isoxazol-3-yl]-N-[(4R)-2-ethyl-3-oxo-isoxazolidin-4-yl]-2-methyl-benzamide; 4-[(5S)-5-(3,5- dichloro-4-fluoro-phenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-N-[(4R)-2-ethyl-3-oxo-isoxazolidin- 4-yl]-2-methyl-benzamide; N-[4-Chloro-3-[[(phenylmethyl)-amino]-carbonyl]-phenyl]-1 -methyl-3- (1,1,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)-1 H-pyrazole-5-carboxamide; N-[4-chloro-3-(cyclo- propylcarbamoyl)phenyl]-2-methyl-5-(1,1,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3- carboxamide; N-[4-chloro-3-[(1-cyanocyclopropyl)carbamoyl]phenyl]-2-methyl-5-(1,1,2,2, 2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3-carboxamide; 2-chloro-N-(1-cyanocyclopropyl)-5-[1-[2-methyl-5-(1,1,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3-yl]pyrazol-4-yl]benzamide; 2-(3-ethylsulfonyl-2-pyridyl)-3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridine, 2-(3-ethylsulfonyl-2-pyridyl)-5-(trifluoromethylsulfonyl)-1,3-benzoxazole; spiropidion, acynonapyr, and benzpyrimoxan; methods and use of these mixtures for combating invertebrate pests such as insects, arachnids or nematodes in and on plants, and for protecting such plants being infested with pests, especially also for protecting plant propagation material as like seeds.
Patent AU-2018316412-A1 (AU)
Title: Dressing
Inventor: DODEL KIRSTEN
IPC: A61F13/02
Filed: 2018-07-03
Abstract: A dressing for application to human or animal skin and/or to medical devices, comprising a fixing web provided with an adhesive on a fixing surface, covering means removably attached to the fixing surface, and support means connected to the covering means and removably attached to an outer surface of the fixing web facing away from the fixing surface, wherein the outer surface has an exposed shaping surface which is at least partially surrounded by the support means.
Patent AU-2018326721-A1 (AU)
Title: Compounds and compositions for IRE1 inhibition
Inventor: KEENAN RICHARD M
IPC: C07D487/04
Filed: 2018-08-31
Abstract: The present invention provides novel compounds, compositions and methods for treating or preventing an IRE1α-related disease or disorder. In certain embodiments, the disease or disorder is selected from the group consisting of a neurodegenerative disease, a demyelinating disease, cancer, an eye disease, a fibrotic disease, and diabetes.
Patent AU-2018345674-A1 (AU)
Title: Electrolytic biocide generating system for use on-board a watercraft
Inventor: COSENTINO LOUIS CIRO
IPC: C02F1/467
Filed: 2018-10-03
Abstract: The present disclosure relates to a biocide generating system for inhibiting bio-fouling within a water system of a watercraft. The water system is configured to draw water from a body of water on which the watercraft is supported. The biocide generating system includes: an electrode arrangement adapted to be incorporated as part of an electrolytic cell through which the water of the water system flows; and a control system that interfaces with the electrode arrangement, the control system including an electrical power circuit for establishing a flow of electrical current between first and second electrodes of the electrode arrangement to generate a biocide in the water within the electrolytic cell, the control system including a switching arrangement operable in a first switch configuration in which the first electrode is an anode and the second electrode is a cathode, the switching arrangement also being operable in a second switch configuration in which the first electrode is a cathode and the second electrode is an anode. an electrode arrangement adapted to be incorporated as part of an electrolytic cell through which the water of the water system flows.
Patent AU-2018355352-A1 (AU)
Title: Fire protection retrofits for high-rise buildings
Inventor: SIMONTACCHI JOHN
IPC: E04B1/94
Filed: 2018-10-24
Abstract: Buildings, particularly high-rise buildings, are retrofitted with a fire resistant liquid-applied material, preferably a material that intumesces with heat, where the exterior of the building is formed of metal clad combustible foam composite panels. Once the fire resistant coating has been applied, new thin panels matching the original fascia are installed outside the original composite panels, with space between, so that the appearance of the building is maintained.
Patent AU-2018356648-A1 (AU)
Title: Coalescence separator, in particular for use in a crankcase ventilation system, crankcase ventilation system and use of a coalescence separator
Inventor: GREIN THOMAS
IPC: B01D39/20
Filed: 2018-10-26
Abstract: The invention relates to a coalescence separator for separating liquid droplets from a gas flow, in particular for separating oil from a crankcase gas flow, comprising a gas inlet, a gas outlet and a multi-layer structure of a coalescence filter medium arranged between the gas inlet and the gas outlet, characterised in that the coalescence filter medium is an in particular wet-laid glass-fibre paper having a single-layer thickness of more than 0.8 mm and at most 5 mm, a basis weight of greater than 80 g/m² and less than 500 g/m², and an air permeability of the single layer of from 350 to 1800 l/m²s.
Patent AU-2018376263-A1 (AU)
Title: Combination of a 4-pyrimidinesulfamide derivative with an SGLT-2 inhibitor for the treatment of endothelin related diseases
Inventor: BELLET MARC
IPC: A61K31/7048
Filed: 2018-11-29
Abstract: The present invention concerns the compound aprocitentan, {5-(4-bromo-phenyl)-6-[2-(5-bromo-pyrimidin-2-yloxy)-ethoxy]-pyrimidin-4-yl}-sulfamide and its use as endothelin receptor antagonist, in combination with an SGLT-2 inhibitor. The invention further relates to pharmaceutical compositions comprising aprocitentan in combination with said SGLT-2 inhibitor. The invention further relates to such pharmaceutical compositions comprising crystalline forms of aprocitentan.
Patent AU-2018378997-A1 (AU)
Title: A method for making a lithographic printing plate
Inventor: HENDRIKX PETER
IPC: G03F7/40
Filed: 2018-11-30
Abstract: A method for making a negative-working lithographic printing plate is disclosed which includes subjecting an image-wise exposed, developed and dried plate precursor to UV LED radiation.
Patent AU-2018384803-A1 (AU)
Title: Fluorinated 4-(substituted amino)phenyl carbamate derivatives
Inventor: FURUYA TAKERU
IPC: C07D217/22
Filed: 2018-12-13
Abstract: The application relates to 4-(substituted amino)phenyl carbamate derivatives, or pharmaceutically acceptable salts or solvates thereof, as KCNQ2/3 potassium channel modulators, and methods of their uses.
Patent AU-2018387279-A1 (AU)
Title: Compositions comprising at least on N-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children
Inventor: GARCIA-RODENAS CLARA
IPC: A61K31/702
Filed: 2018-12-20
Abstract: This invention relates to compositions for use in the promotion of the development and/or of the growth of the surface area of the small intestine and in the associated improvement of the digestive capacity in an infant or in a young child.